MeSH term
Frequency | Condition_Probility | English Abstract | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
HLA Antigens/*genetics | 26 | 3.0 |
Histocompatibility Antigens Class I/genetics | 7 | 7.0 |
Humans | 48 | 0.0 |
*Membrane Proteins | 30 | 2.0 |
Mutation | 10 | 0.0 |
Adult | 9 | 0.0 |
Aged | 8 | 0.0 |
Base Sequence | 10 | 0.0 |
Cohort Studies | 2 | 0.0 |
Female | 16 | 0.0 |
Hemochromatosis/epidemiology/*genetics | 2 | 15.0 |
Heterozygote | 6 | 0.0 |
Male | 15 | 0.0 |
Middle Aged | 10 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Mutation/*genetics | 4 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Animals | 8 | 0.0 |
Cell Line | 2 | 0.0 |
DNA Primers | 5 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Exons | 3 | 0.0 |
Genome, Human | 2 | 0.0 |
Histocompatibility Antigens Class I/*genetics | 24 | 7.0 |
Introns | 2 | 0.0 |
*Major Histocompatibility Complex | 3 | 1.0 |
Polymorphism, Genetic | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
France | 2 | 0.0 |
Gene Frequency | 4 | 0.0 |
Genes, MHC Class I/*genetics | 2 | 2.0 |
Genotype | 5 | 0.0 |
Hemochromatosis/*genetics | 13 | 13.0 |
Pedigree | 5 | 0.0 |
Point Mutation | 4 | 0.0 |
*DNA Mutational Analysis | 2 | 1.0 |
Homozygote | 7 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
*Genes, MHC Class I | 8 | 3.0 |
Mice | 4 | 0.0 |
*Multigene Family | 2 | 0.0 |
HLA Antigens/genetics | 6 | 1.0 |
Haplotypes | 7 | 0.0 |
HLA-A Antigens/*genetics | 2 | 1.0 |
Hemochromatosis/blood/*genetics | 2 | 22.0 |
*Homozygote | 2 | 1.0 |
Iron/blood | 3 | 3.0 |
Phlebotomy | 2 | 8.0 |
Ferritin/blood | 3 | 1.0 |
Genetic Heterogeneity | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Chromosomes, Human, Pair 6 | 4 | 2.0 |
Linkage (Genetics) | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Cysteine/genetics | 3 | 2.0 |
*Gene Frequency | 3 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Tyrosine/genetics | 3 | 6.0 |
Alleles | 6 | 0.0 |
Hemochromatosis/*genetics/immunology | 5 | 55.0 |
Linkage Disequilibrium | 3 | 0.0 |
*Point Mutation | 5 | 0.0 |
Reference Values | 3 | 0.0 |
Comparative Study | 9 | 0.0 |
Iron/*metabolism | 3 | 2.0 |
*Mutation | 6 | 0.0 |
Chromosomes, Human, Pair 6/genetics | 3 | 2.0 |
Cysteine | 2 | 1.0 |
Liver/pathology | 2 | 1.0 |
Transferrin/analysis | 2 | 2.0 |
Pregnancy | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
Genetic Markers | 3 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Major Histocompatibility Complex/*genetics | 3 | 1.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Genes, MHC Class I | 2 | 1.0 |
Hemochromatosis/genetics | 2 | 5.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Major Histocompatibility Complex | 3 | 1.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Evolution | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Pseudogenes | 2 | 1.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
